The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Long-Term Side Effects Of Mounjaro — What The NHS Says
Mounjaro (tirzepatide) is a prescription-only GLP-1 and GIP receptor agonist approved in the UK for weight management in adults. While short-term side effects like nausea are well-documented, many people wonder about potential long-term effects. Current evidence from clinical trials and NHS guidance suggests Mounjaro is generally well-tolerated over extended periods, though some side effects may persist or emerge over time. This guide explains what the NHS and MHRA monitoring data tell us about long-term Mounjaro use, and when to seek advice from your GP.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Long-Term Safety Data Shows About Mounjaro
Mounjaro is subject to additional MHRA monitoring (Black Triangle ▼ status), meaning safety data is reviewed continuously as more people use it in the UK. The SURMOUNT clinical trials tracked participants for up to 72 weeks, showing sustained weight loss without accumulating serious adverse events. However, real-world UK use extends beyond trial timescales, and NHS specialists continue monitoring long-term outcomes.
Long-term side effects reported include:
- Gastrointestinal symptoms: Nausea, diarrhoea, and constipation may persist but often improve as the body adjusts; however, some users experience ongoing digestive effects
- Hair loss (alopecia): Reported in clinical trials; typically related to gradual weight management rather than the drug itself, and usually reversible
- Appetite suppression: Remains sustained, which is the intended effect, but requires consistent monitoring to ensure adequate nutrition
- Injection site reactions: Redness or bruising usually resolves but may recur with each weekly injection using the KwikPen device
- Fatigue: Some users report persistent tiredness; this may improve with dose optimisation or be managed through GP review
The key difference between Mounjaro and competing GLP-1 medications like Wegovy is its dual GIP and GLP-1 mechanism, which may affect long-term tolerability differently, though head-to-head long-term studies in UK populations are still emerging.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Guidance On Long-Term Mounjaro Monitoring
If you are prescribed Mounjaro through an NHS tier 3 specialist weight management service, your GP and specialist team will monitor you regularly — typically every 3–6 months — to assess both weight loss progress and side effect burden. You should report any new or worsening symptoms immediately to your healthcare provider. Particular concern areas include signs of pancreatitis (severe upper abdominal pain), gallbladder problems, or changes in vision (especially if you have diabetes), as these require urgent medical attention and may warrant stopping treatment.
Long-term use also requires ongoing assessment of whether the benefits of weight loss outweigh any persistent side effects. Your GP can adjust your tirzepatide dose, pause treatment, or explore alternatives if long-term tolerability becomes an issue. The NHS emphasises that weight management is a marathon, not a sprint — sustainable use matters more than maximum doses.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
How long do Mounjaro side effects typically last?
Most common side effects like nausea peak in the first 2–4 weeks and improve within 8–12 weeks as your body adjusts. However, some gastrointestinal effects can persist throughout long-term treatment. Your GP can help manage persistent symptoms through dietary adjustments or dose optimisation. Always report ongoing side effects at your regular NHS monitoring appointments.
Is hair loss from Mounjaro permanent?
Hair loss associated with Mounjaro is usually temporary and related to gradual weight management rather than the medication itself. It typically reverses once weight stabilises. If you experience significant hair loss, discuss it with your GP — nutritional deficiencies should be ruled out, especially if you are losing weight quickly.
Can you take Mounjaro long-term indefinitely?
Yes, Mounjaro can be used long-term if it remains effective and tolerable. However, NHS guidance emphasises regular monitoring with your GP or specialist. Long-term use requires ongoing assessment of benefits versus side effects. Some people may pause treatment, switch medications, or explore maintenance approaches with professional guidance.
What happens if long-term Mounjaro side effects become unbearable?
Contact your GP immediately. Treatment options include dose reduction, temporary pauses, switching to an alternative GLP-1 medication like Wegovy, or exploring other weight management approaches. Your healthcare provider will help you find a sustainable solution. Never stop Mounjaro without medical advice.
Does the NHS continue prescribing Mounjaro after weight loss goals are reached?
This depends on your individual circumstances and NHS tier 3 service guidance. Some people continue at a lower maintenance dose; others transition to lifestyle management. Your specialist will discuss long-term plans with you. Using our GLP-1 weight loss calculator can help you understand potential weight loss trajectories and discuss realistic long-term goals with your healthcare team.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.